Mapp Biopharmaceutical to make ZMapp Ebola treatment for Canada
by Staff from Outbreak News Today on (#B0BT)
The Honourable Rona Ambrose, Minister of Health, and Canada's Chief Public Health Officer, Dr. Gregory Taylor, yesterday announced a $4.5 million USD contract between the Government of Canada and Mapp Biopharmaceutical, Inc. to manufacture a number of courses of ZMappa monoclonal antibody (mAb) treatment for Ebola. The ZMappa treatment, developed by Mapp Biopharmaceutical, uses two ["]
